Media coverage of new Cochrane Review on HPV vaccine for cervical cancer prevention in girls and women

New evidence published in the Cochrane Library shows that human papilloma virus (HPV) vaccines protect against cervical lesions in young women, particularly in those who are vaccinated between the ages of 15 and 26. It also summarizes findings on harms that have been assessed in randomized controlled trials. Below is a round-up for some of the media coverage.